ATE423771T1 - Tetrahydrochinolinderivate - Google Patents
TetrahydrochinolinderivateInfo
- Publication number
- ATE423771T1 ATE423771T1 AT03796105T AT03796105T ATE423771T1 AT E423771 T1 ATE423771 T1 AT E423771T1 AT 03796105 T AT03796105 T AT 03796105T AT 03796105 T AT03796105 T AT 03796105T AT E423771 T1 ATE423771 T1 AT E423771T1
- Authority
- AT
- Austria
- Prior art keywords
- tetrahydrochinoline
- derivatives
- tetrahydrochinoline derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
- C07D215/44—Nitrogen atoms attached in position 4 with aryl radicals attached to said nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43504002P | 2002-12-20 | 2002-12-20 | |
| EP02102866 | 2002-12-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE423771T1 true ATE423771T1 (de) | 2009-03-15 |
Family
ID=39311811
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03796105T ATE423771T1 (de) | 2002-12-20 | 2003-12-16 | Tetrahydrochinolinderivate |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US7858794B2 (de) |
| EP (1) | EP1578726B1 (de) |
| JP (1) | JP4545001B2 (de) |
| AR (1) | AR042630A1 (de) |
| AT (1) | ATE423771T1 (de) |
| AU (1) | AU2003298363B2 (de) |
| BR (1) | BR0317518A (de) |
| CA (1) | CA2508952C (de) |
| CL (1) | CL2003002685A1 (de) |
| ES (1) | ES2321830T3 (de) |
| NZ (1) | NZ540578A (de) |
| PE (1) | PE20040928A1 (de) |
| PL (1) | PL377318A1 (de) |
| RS (1) | RS51293B (de) |
| RU (1) | RU2328488C2 (de) |
| TW (1) | TWI306855B (de) |
| UA (1) | UA81442C2 (de) |
| WO (1) | WO2004056780A2 (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2452606C (en) * | 2001-07-02 | 2011-09-13 | Akzo Nobel N.V. | Tetrahydroquinoline derivatives |
| TWI306855B (en) | 2002-12-20 | 2009-03-01 | Organon Nv | Tetrahydroquinoline derivatives |
| TWI322012B (en) * | 2002-12-20 | 2010-03-21 | Organon Nv | Tetrahydroquinoline derivatives |
| US7691848B2 (en) | 2005-03-02 | 2010-04-06 | Wyeth | Pyrrolobenzodiazepine arylcarboxamides and derivatives thereof as follicle-stimulating hormone receptor antagonists |
| MX2007014085A (es) | 2005-05-12 | 2008-02-07 | Wyeth Corp | Pirrolobenzodiazepinas y derivados de carboxamida heterociclica como antagonistas de receptor de hormona estimulante del foliculo. |
| CN101208342A (zh) * | 2005-06-09 | 2008-06-25 | 惠氏公司 | 作为促卵泡激素受体拮抗剂的吡咯并苯并二氮杂䓬吡啶羧酰胺和衍生物 |
| US8106190B2 (en) | 2005-11-30 | 2012-01-31 | Astellas Pharma Inc. | 2-aminobenzamide derivatives |
| WO2008071455A1 (en) * | 2006-12-15 | 2008-06-19 | Bayer Schering Pharma Aktiengesellschaft | Bicyclic acyltryptophanols |
| EP1956016A1 (de) * | 2006-12-15 | 2008-08-13 | Bayer Schering Pharma Aktiengesellschaft | Bizyklische Acyltryptophanole |
| GB0705656D0 (en) * | 2007-03-23 | 2007-05-02 | Addex Pharmaceuticals Sa | Novel compounds E1 |
| TW200918058A (en) | 2007-08-31 | 2009-05-01 | Organon Nv | TSH receptor antagonizing tetrahydroquinoline compounds |
| US8071587B2 (en) * | 2009-05-27 | 2011-12-06 | N. V. Organon | (Dihydro)imidazoiso[5,1-A]quinolines |
| TW201116531A (en) * | 2009-07-29 | 2011-05-16 | Organon Nv | Ring-annulated dihydropyrrolo[2,1-a]isoquinolines |
| US8431564B2 (en) | 2009-07-29 | 2013-04-30 | Merck Sharp & Dohme B.V. | Ring-annulated dihydropyrrolo[2,1-α]isoquinolines |
| WO2017192847A1 (en) * | 2016-05-04 | 2017-11-09 | University Of Cincinnati | Female fertility therapies |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2686182A (en) | 1950-12-07 | 1954-08-10 | Basf Ag | O-hydroxy-dihydro-quinoline carboxylic acids |
| DE3879031T2 (de) | 1987-08-08 | 1993-06-24 | Akzo Nv | Kontrazeptives implantat. |
| DK0800519T3 (da) * | 1994-12-22 | 2004-03-01 | Ligand Pharm Inc | Steroidreceptormodulatorforbindelser og fremgangsmåder |
| DE69921147T2 (de) * | 1998-08-07 | 2005-02-24 | Applied Research Systems Ars Holding N.V. | Fsh mimetika zur behandlung von infertilität |
| US6200963B1 (en) | 1999-03-31 | 2001-03-13 | American Home Products Corporation | Aryl sulfonic acids as FSH antagonists |
| CA2452606C (en) * | 2001-07-02 | 2011-09-13 | Akzo Nobel N.V. | Tetrahydroquinoline derivatives |
| TWI322012B (en) * | 2002-12-20 | 2010-03-21 | Organon Nv | Tetrahydroquinoline derivatives |
| TWI306855B (en) | 2002-12-20 | 2009-03-01 | Organon Nv | Tetrahydroquinoline derivatives |
| TW592127U (en) * | 2003-05-19 | 2004-06-11 | Tatung Co | Network-type physiology monitoring device |
-
2003
- 2003-12-15 TW TW092135447A patent/TWI306855B/zh not_active IP Right Cessation
- 2003-12-16 JP JP2004561499A patent/JP4545001B2/ja not_active Expired - Fee Related
- 2003-12-16 PL PL377318A patent/PL377318A1/pl not_active Application Discontinuation
- 2003-12-16 US US10/540,336 patent/US7858794B2/en not_active Expired - Lifetime
- 2003-12-16 WO PCT/EP2003/051025 patent/WO2004056780A2/en active Application Filing
- 2003-12-16 CA CA2508952A patent/CA2508952C/en not_active Expired - Lifetime
- 2003-12-16 BR BR0317518-9A patent/BR0317518A/pt active Search and Examination
- 2003-12-16 AU AU2003298363A patent/AU2003298363B2/en not_active Ceased
- 2003-12-16 NZ NZ540578A patent/NZ540578A/en not_active IP Right Cessation
- 2003-12-16 EP EP03796105A patent/EP1578726B1/de not_active Expired - Lifetime
- 2003-12-16 UA UAA200505288A patent/UA81442C2/xx unknown
- 2003-12-16 AT AT03796105T patent/ATE423771T1/de not_active IP Right Cessation
- 2003-12-16 RU RU2005122946/04A patent/RU2328488C2/ru not_active IP Right Cessation
- 2003-12-16 RS YUP-2005/0457A patent/RS51293B/sr unknown
- 2003-12-16 ES ES03796105T patent/ES2321830T3/es not_active Expired - Lifetime
- 2003-12-18 CL CL200302685A patent/CL2003002685A1/es unknown
- 2003-12-19 AR ARP030104729A patent/AR042630A1/es unknown
-
2004
- 2004-01-05 PE PE2004000023A patent/PE20040928A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US7858794B2 (en) | 2010-12-28 |
| JP4545001B2 (ja) | 2010-09-15 |
| CL2003002685A1 (es) | 2005-04-08 |
| RU2005122946A (ru) | 2005-12-20 |
| RU2328488C2 (ru) | 2008-07-10 |
| CA2508952C (en) | 2011-09-13 |
| TWI306855B (en) | 2009-03-01 |
| ES2321830T3 (es) | 2009-06-12 |
| PE20040928A1 (es) | 2004-12-25 |
| TW200418800A (en) | 2004-10-01 |
| AU2003298363A1 (en) | 2004-07-14 |
| RS20050457A (en) | 2007-08-03 |
| JP2006512347A (ja) | 2006-04-13 |
| AU2003298363B2 (en) | 2009-09-24 |
| AR042630A1 (es) | 2005-06-29 |
| US20060142334A1 (en) | 2006-06-29 |
| UA81442C2 (en) | 2008-01-10 |
| WO2004056780A2 (en) | 2004-07-08 |
| WO2004056780A3 (en) | 2004-08-05 |
| NZ540578A (en) | 2006-12-22 |
| RS51293B (sr) | 2010-12-31 |
| PL377318A1 (pl) | 2006-01-23 |
| CA2508952A1 (en) | 2004-07-08 |
| EP1578726B1 (de) | 2009-02-25 |
| EP1578726A2 (de) | 2005-09-28 |
| BR0317518A (pt) | 2005-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE478870T1 (de) | Spiroindolinpiperidinderivate | |
| ATE460418T1 (de) | Heterocyclocarboxamidderivate | |
| DK1551802T3 (da) | Indol-3-svovlderivater | |
| ATE467631T1 (de) | Chinuclidinamidderivate | |
| IS7720A (is) | Píperidín-N-oxíð-afleiður | |
| ATE438644T1 (de) | Chinazolinderivate | |
| DK1474408T3 (da) | N-Phenyl-2-pyrimidinaminderivater | |
| ATE340782T1 (de) | Piperidinbenzolsulfonamidderivate | |
| NO20054136D0 (no) | Imidazol-4-yl-etynyl-pyridin-derivater | |
| DK1682493T3 (da) | Amidoacetonitrilderivater | |
| ATE352550T1 (de) | Chinazolinderivate | |
| IS8364A (is) | N-þíasól-2-ýl-bensamíð afleiður | |
| ATE335729T1 (de) | 3h-chinazoline -4-on derivaten | |
| IS8045A (is) | Púrín-6-ón-afleiður | |
| ATE423771T1 (de) | Tetrahydrochinolinderivate | |
| ATA1572002A (de) | Managementspleisskassette | |
| ATE457299T1 (de) | 4-hydroxymethyl-1-aryl-cyclohexylamin-derivativ | |
| DK1706373T3 (da) | Amidoacetonitrilderivater | |
| DE50306277D1 (de) | 4-alkyl-/4-alkenyl-/4-alkinylmethyl/-1-arylcyclohexylamin-derivate | |
| ATA4142004A (de) | Trägerverbau | |
| ATA19152002A (de) | Hubkupplung | |
| IS7906A (is) | Afleiður própargýl-tríflúorómetoxý-amínó-benzóþíazóls | |
| AT5889U3 (de) | Brennholzspleisser | |
| ATA16872002A (de) | Zwischenstück | |
| ATE395327T1 (de) | Amidoacetonitrilderivate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |